Genetically encoded Runx3 and CD4+intestinal epithelial lymphocyte deficiencies link SKG mouse and human predisposition to spondyloarthropathy

Disturbances in immune regulation, intestinal dysbiosis and inflammation characterize ankylosing spondylitis (AS), which is associated with RUNX3 loss-of-function variants. ZAP70W163C mutant (SKG) mice have reduced ZAP70 signaling, spondyloarthritis and ileitis. In small intestine, Foxp3+ regulatory T cells (Treg) and CD4+CD8 alpha alpha+TCR alpha beta+ intraepithelial lymphocytes (CD4-IEL) control inflammation. TGF-beta and retinoic acid (RA)producing dendritic cells and MHC-class II+ intestinal epithelial cells (IEC) are required for Treg and CD4-IEL differentiation from CD4+ conventional or Treg precursors, with upregulation of Runx3 and suppression of ThPOK. We show in SKG mouse ileum, that ZAP70W163C or ZAP70 inhibition prevented CD4-IEL but not Treg differentiation, dysregulating Runx3 and ThPOK. TGF-beta/RA-mediated CD4-IEL development, T-cell IFN-gamma production, MHC class-II+ IEC, tissue-resident memory T-cell and Runx3-regulated genes were reduced. In AS intestine, CD4-IEL were decreased, while in AS blood CD4+CD8+ T cells were reduced and Treg increased. Thus, genetically-encoded TCR signaling dysfunction links intestinal T-cell immunodeficiency in mouse and human spondyloarthropathy.

Automated summary

Loss-of-function variants in RUNX3 are associated with ankylosing spondylitis (AS) and lead to immune dysregulation, intestinal dysbiosis, and inflammation. In AS, CD4-IEL cells and CD4+CD8+ T cells are decreased, while Treg cells are increased. TCR signaling dysfunction plays a role in the intestinal T-cell immunodeficiency observed in AS.